Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0J6MM
|
|||
Drug Name |
PMID25522065-Compound-37
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
MERCK SHARP &amDOHME CORP. LIN, Linus SOLL, Richard DONG, Jingchao WU, Hao SUZUKI, Takao HU, Bin LIU, Dejun HAO, Jinglai XU, Ming
|
|||
Structure |
Download2D MOL |
|||
Formula |
C23H24FNO4
|
|||
Canonical SMILES |
CC1=C(C=CC(=C1)N2C=CC(=CC2=O)OCC3=CC=C(C=C3)F)OCC(C)(C)O
|
|||
InChI |
1S/C23H24FNO4/c1-16-12-19(8-9-21(16)29-15-23(2,3)27)25-11-10-20(13-22(25)26)28-14-17-4-6-18(24)7-5-17/h4-13,27H,14-15H2,1-3H3
|
|||
InChIKey |
WCMFUWBVIKILDJ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Melanin-concentrating hormone receptor 1 (MCHR1) | Target Info | Antagonist | [1] |
Target's Patent Info | Melanin-concentrating hormone receptor 1 (MCHR1) | Target's Patent Info | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Reactome | Peptide ligand-binding receptors | |||
G alpha (q) signalling events | ||||
G alpha (i) signalling events | ||||
WikiPathways | GPCRs, Class A Rhodopsin-like | |||
Gastrin-CREB signalling pathway via PKC and MAPK | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Novel MCH1 receptor antagonists: a patent review.Expert Opin Ther Pat. 2015 Feb;25(2):193-207. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.